Fast-dissolving non-hormonal contraception tablet for on-demand use
Official title: Fast Dissolving MM008 Tablet for Instant On-Demand Non-Hormonal Contraception
Funded at Mucommune, LLC · NIH-11415806 · Data updated 2026-11-12
A non-hormonal, fast-acting tablet is being developed to provide discreet, on-demand contraception for women who prefer not to use hormones.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Mucommune, LLC NIH-funded |
| Lab location | 1 site (Morrisville, UNITED STATES) |
| Project start | September 15, 2025 |
| Project end | August 31, 2027 |
| Funding year | 2026 |
| Award (this year) | $1,168,977 |
| NIH project number | 5R44HD118898-02 |
| Project ID | NIH-11415806 on NIH RePORTER |
Who could benefit from this research
✓Could help
Women seeking non-hormonal, on-demand contraception who are comfortable with antibody-based delivery.
✕Less likely to help
Individuals seeking hormonal contraception or non-antibody-based methods may not benefit.
What this research studies
This project aims to create a quick-dissolving antibody-based tablet (FDAT) that delivers non-hormonal contraception for on-demand use during intercourse. The approach uses proprietary anti-sperm monoclonal antibodies formulated into a fast-dissolving tablet to achieve rapid, extended protection. The work focuses on safe delivery, prolonged activity, and minimal mess or inconvenience for users. If successful, this could offer a hormone-free option with flexible dosing that aligns with diverse user preferences.
Why it matters
Potential benefit: If successful, it could provide a convenient, non-hormonal on-demand contraception option with rapid action and extended protection.
How similar studies have gone: Previous work with monoclonal antibodies for contraception has shown potential, but the specific fast-dissolving tablet approach is novel.
Where this research is happening
-
Mucommune, LLC
Morrisville, United States Active
Researchers
- Principal investigator: Kushiro, Keiichiro — Mucommune, LLC
- Study coordinator: Kushiro, Keiichiro
Related research
Other NIH-funded projects on the same topics.
-
Mobile health support to boost PrEP and contraception use among young women in Zambia
A mobile health program helps female university students in Zambia learn about and access HIV prevention and contraception.
-
Blocking CFTR in the cervix to prevent conception without hormones
A non-hormonal approach aims to stop sperm from entering the uterus by making cervical mucus too thick for sperm, potentially offering a new contraception option.
-
Long‑lasting antibody vaginal ring for non‑hormonal birth control
Testing a vaginal ring that slowly releases an antibody to trap sperm and prevent pregnancy for people seeking non‑hormonal contraception.
-
A woman-controlled, nonhormonal on-demand contraceptive device
This project is creating a woman-controlled vaginal device that releases a fabric-like polymer which thickens on contact with semen to help prevent pregnancy.
-
Vaginal ring releasing non-hormonal antibody contraception for month-long use
A monthly vaginal ring delivers a non-hormonal antibody-based contraceptive, offering a convenient, user-controlled option for women who want to avoid daily dosing or invasive procedures.
-
On-demand non-hormonal vaginal contraception with a fast-dissolving antibody tablet
A new on-demand vaginal tablet dissolves quickly to release a monoclonal antibody for non-hormonal contraception.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.